OZEQVO Trademark

Trademark Overview


On Wednesday, December 13, 2023, a trademark application was filed for OZEQVO with the United States Patent and Trademark Office. The USPTO has given the OZEQVO trademark a serial number of 98311936. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, September 9, 2024. This trademark is owned by MERCK SHARP & DOHME LLC. The OZEQVO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Pharmaceutical preparations, namely, anti-bacterials, antibiotics, anti-fungals, anti-infectives, anti-inflammatories, anti-parasitics, and antivirals; human vaccine preparations; Inhalers filled with pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and disorders
ozeqvo

General Information


Serial Number98311936
Word MarkOZEQVO
Filing DateWednesday, December 13, 2023
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateMonday, September 9, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 15, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Pharmaceutical preparations, namely, anti-bacterials, antibiotics, anti-fungals, anti-infectives, anti-inflammatories, anti-parasitics, and antivirals; human vaccine preparations; Inhalers filled with pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, December 13, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMERCK SHARP & DOHME LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressRahway, NJ 07065

Trademark Events


Event DateEvent Description
Wednesday, December 13, 2023NEW APPLICATION ENTERED
Sunday, March 17, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 14, 2024ASSIGNED TO EXAMINER
Wednesday, September 4, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 4, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 4, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 6, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 25, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, June 14, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, June 14, 2024NON-FINAL ACTION E-MAILED
Friday, June 14, 2024NON-FINAL ACTION WRITTEN